Oxlumo Injection, Solution
Product Images NDC 71336-1002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxlumo (NDC 71336-1002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alnylam Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lumasiran 01)

FDA Label Image

Figure 1 (Lumasiran 02)

FDA Label Image

Figure 2 (Lumasiran 03)

FDA Label Image

Principal Display Panel (0.5 mL Vial Carton)

Principal Display Panel (0.5 mL Vial Carton)
This is a pharmaceutical product information about an injection called OXLUMO containing tumasiran. The excipients used in the injection include water, and each 0.5mL injection contains 94.5mg of USF and Prosphan A USF. The text also provides the product code, NDG74336-10024, and suggests storing the injection in its original packaging. Furthermore, it contains references to instructions (given reference numbers) for storing and purchasing the drug. AlertDialogue box saying "Rx Only" suggests this is a prescription-only medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.